Dihydrocurcumin regulates glucose intake, moderates SREBP-1C/PPAR-α/pAKT expression, and decreases levels of triglycerides, oxidative stress, and insulin resistance (Yu et al., 2018). Here, PPARA is linked to Insulin resistance.